Consequences of interactions between human neutrophils and Staphylococcus aureus
人类中性粒细胞和金黄色葡萄球菌之间相互作用的后果
基本信息
- 批准号:9230328
- 负责人:
- 金额:$ 38.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-09-01 至 2020-02-29
- 项目状态:已结题
- 来源:
- 关键词:AffectAlpha CellAntibiotic TherapyAntibioticsApoptosisApoptoticBiochemicalBiologyCaspaseCell Cycle ProteinsCell DeathCellsCessation of lifeClinicalCommunitiesComplexCytolysisCytoplasmCytoplasmic GranulesDataDependenceDiseaseEnvironmentEpidemicEquus caballusEventExhibitsExperimental ModelsExtensive NecrosisFailureGenus staphylococcusHost DefenseHumanImmuneIndividualInfectionInflammationInflammatory ResponseIngestionInnate Immune SystemInvadedLinkLungMediatingMembraneMethicillin ResistanceMicrobeMolecularMorbidity - disease rateMusNADPH OxidaseNecrosisNeoplasm MetastasisOrganismOxidantsPathway interactionsPhagocytesPhagocytosisPhagosomesPhenotypeProliferating Cell Nuclear AntigenProtein KinaseProteinsRIPK1 geneRecruitment ActivityRegulationRegulatory PathwayRelapseRoleSignal PathwaySignal TransductionSkinStaphylococcal InfectionsStaphylococcus aureusSupportive careSystemTNF geneTestingTherapeutic InterventionTissuesWorkantimicrobialbasecytokineinnovationinsightmacrophagemicrobicidemicroorganismmonocytemortalityneutrophilnew therapeutic targetnovelpathogenpublic health relevanceresponsetherapeutic target
项目摘要
DESCRIPTION (provided by applicant): Human polymorphonuclear leukocytes (PMN) are at the front-line of cellular innate immune-mediated host defense against infection, especially those caused by organisms such as S. aureus (SA). Despite the potent PMN antimicrobial system, 10-20% of ingested SA remained viable, but not replicating, in PMN. Persistence of SA within PMN has profound clinical consequences, as signature features of staphylococcal infection are relapse, metastases, and failure of antibiotics to which SA are susceptible. In our ongoing studies of the fate of SA-laden human PMN and their interactions with monocyte-derived macrophages (MØ), we have made several novel findings: PMN-SA (1) early after phagocytosis of SA display a phenotype that is atypical for pathogen-induced apoptosis; (2) are not efficiently efferocytosed by MØ; (3) maintain sustained levels of proliferating cell nuclear antigen (PCNA), a cell-cycle protein expressed in PMN cytoplasm, and recently linked to prolonging PMN survival by scavenging procaspases; and (4) lyse in a fashion most consistent with necroptosis, a caspase-independent programmed necrotic cell death pathway never previously described in PMN but involving a multicomponent cytoplasmic signaling complex and dependence on receptor-interacting protein kinase 1 (RIP1K). We reason that these cellular events in and between PMN-SA and MØ drive the clinical hallmarks of SA infection and propose studies to explore of the mechanisms underlying our novel observations. Aim 1: Determine the mechanisms underlying the failed efferocytosis of PMN-SA by M¿ 1A: Identify signals generated by PMN-SA that promote efferocytosis by MØ 1B: Identify signals generated by PMN-SA that actively block efferocytosis by MØ 1C: Identify signaling pathways and effector responses of MØ challenged with PMN-SA 1D: Determine the role of ectosomes generated by PMN-SA to modulate efferocytosis by MØ Aim 2: Identify cellular components, biochemical events, and signaling pathways underlying necroptosis of PMN-SA 2A: Determine the composition and regulation of the ripoptosome in PMN-SA 2B: Determine the contribution of PCNA to the initial prolonged survival and eventual lysis of PMN-SA 2C: Determine the signaling pathways engaged as PMN-SA proceed to necroptosis 2D: Determine the role of TNF-dependent signaling in necroptosis of PMN-SA Our studies will identify mechanisms responsible for the atypical apoptosis, failed efferocytosis, and necrotic death of PMN-SA, thereby providing novel insights into fundamental aspects of phagocyte control of the inflammatory response and new potential therapeutic targets.
描述(由申请人提供):人多形核白细胞(PMN)处于细胞先天免疫介导的宿主防御感染的第一线,特别是由诸如沙门氏菌等生物体引起的感染。金黄色葡萄球菌(SA)。尽管有有效的PMN抗微生物系统,但10-20%的摄入SA在PMN中保持活力,但不复制。中性粒细胞内SA的持续存在具有深远的临床后果,因为葡萄球菌感染的特征是复发、转移和SA敏感的抗生素治疗失败。 在我们正在进行的关于SA负载的人PMN的命运及其与单核细胞衍生的巨噬细胞(MMCs)的相互作用的研究中,我们获得了几个新的发现:PMN-SA(1)在吞噬SA后的早期表现出病原体诱导的凋亡的非典型表型;(3)维持持续水平的增殖细胞核抗原(PCNA),一种在PMN胞质中表达的细胞周期蛋白,最近与通过清除半胱氨酸蛋白酶原延长PMN存活有关;和(4)以与坏死性凋亡最一致的方式裂解,坏死性凋亡是一种以前从未在PMN中描述过的不依赖半胱天冬酶的程序性坏死细胞死亡途径,但涉及多组分胞质信号复合物和对受体相互作用蛋白激酶1(RIP 1 K)的依赖。我们的理由是,这些细胞事件和之间的PMN-SA和MPEG4驱动SA感染的临床标志,并提出研究,探索我们的新观察的机制。目标1:确定由M?1A引起的PMN-SA胞饮失败的潜在机制:确定由PMN-SA产生的促进由M?1B引起的胞饮的信号:确定由PMN-SA产生的主动阻断由M?1C引起的胞饮的信号:确定由PMN-SA激发的M?1D的信号通路和效应器应答:确定由PMN-SA产生的外核体调节由M?1B引起的胞饮的作用目的2:确定PMN-SA坏死性凋亡的细胞成分、生化事件和信号通路2A:确定PMN-SA中核糖体的组成和调节2B:确定PCNA对PMN-SA最初延长的存活和最终溶解的贡献2C:确定PMN-SA进行坏死性凋亡时参与的信号通路2D:确定TNF α依赖性信号传导在PMN-SA坏死性凋亡中的作用我们的研究将确定导致非典型凋亡、细胞凋亡失败和PMN-SA坏死性死亡的机制,从而为吞噬细胞控制炎症反应的基本方面和新的潜在治疗靶点提供新的见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
William M. Nauseef其他文献
Neutrophil dysfunction in the pathogenesis of cystic fibrosis
中性粒细胞功能障碍在囊性纤维化发病机制中的作用
- DOI:
10.1182/blood.2021014699 - 发表时间:
2022-04-28 - 期刊:
- 影响因子:23.100
- 作者:
Guoshun Wang;William M. Nauseef - 通讯作者:
William M. Nauseef
Insights into myeloperoxidase biosynthesis from its inherited deficiency
- DOI:
10.1007/s001090050265 - 发表时间:
1998-08-26 - 期刊:
- 影响因子:4.200
- 作者:
William M. Nauseef - 通讯作者:
William M. Nauseef
755: Neutrophil Stimulation with Mycobacterium Bovis Bacillus Calmette-Guérin (BCG) Results in the Upregulation of Surface-Bound and Soluble Functional TRAIL/APO-2L
- DOI:
10.1016/s0022-5347(18)34924-3 - 发表时间:
2005-04-01 - 期刊:
- 影响因子:
- 作者:
Thomas S. Griffith;Troy J. Kemp;Aaron T. Ludwig;James K. Earel;Jill M. Moore;Bonita Moses;William M. Nauseef - 通讯作者:
William M. Nauseef
Immunochemical and Electrophoretic Analyses of Phosphorylated Native and Recombinant Neutrophil Oxidase Component p47-<em>Phox</em>
- DOI:
10.1182/blood.v76.12.2622.2622 - 发表时间:
1990-12-15 - 期刊:
- 影响因子:
- 作者:
William M. Nauseef;Bryan D. Volpp;Robert A. Clark - 通讯作者:
Robert A. Clark
William M. Nauseef的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('William M. Nauseef', 18)}}的其他基金
Determinants of human neutrophil fate after phagocytosis
吞噬作用后人类中性粒细胞命运的决定因素
- 批准号:
10092904 - 财政年份:2018
- 资助金额:
$ 38.13万 - 项目类别:
Determinants of human neutrophil fate after phagocytosis
吞噬作用后人类中性粒细胞命运的决定因素
- 批准号:
10328225 - 财政年份:2018
- 资助金额:
$ 38.13万 - 项目类别:
Consequences of interactions between human neutrophils and Staphylococcus aureus
人类中性粒细胞和金黄色葡萄球菌之间相互作用的后果
- 批准号:
9131612 - 财政年份:2015
- 资助金额:
$ 38.13万 - 项目类别:
Early airway innate immune responses to F. tularensis
对土拉弗朗西斯菌的早期气道先天免疫反应
- 批准号:
8305636 - 财政年份:2011
- 资助金额:
$ 38.13万 - 项目类别:
Early airway innate immune responses to F. tularensis
对土拉弗朗西斯菌的早期气道先天免疫反应
- 批准号:
7920676 - 财政年份:2010
- 资助金额:
$ 38.13万 - 项目类别:
Human neutrophils, phospholipase A2 and S.aureus: microbial targets and responses
人中性粒细胞、磷脂酶 A2 和金黄色葡萄球菌:微生物靶标和反应
- 批准号:
8195608 - 财政年份:2009
- 资助金额:
$ 38.13万 - 项目类别:
Human neutrophils, phospholipase A2 and S.aureus: microbial targets and responses
人中性粒细胞、磷脂酶 A2 和金黄色葡萄球菌:微生物靶标和反应
- 批准号:
7791569 - 财政年份:2009
- 资助金额:
$ 38.13万 - 项目类别:
Human neutrophils and Staphylcoccus aureus: microbial targets and responses
人类中性粒细胞和金黄色葡萄球菌:微生物靶标和反应
- 批准号:
8762232 - 财政年份:2009
- 资助金额:
$ 38.13万 - 项目类别:
相似海外基金
The Role of Arginine Transport on Pancreatic Alpha Cell Proliferation and Function
精氨酸转运对胰腺α细胞增殖和功能的作用
- 批准号:
10678248 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
Alpha cell-derived Extracellular Vesicles and Maternal Insulin Production
α细胞来源的细胞外囊泡和母体胰岛素的产生
- 批准号:
10681939 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
Targeting alpha-cell GPCRs to stimulate glucagon and counter hypoglycemia
靶向 α 细胞 GPCR 刺激胰高血糖素并对抗低血糖
- 批准号:
10427574 - 财政年份:2022
- 资助金额:
$ 38.13万 - 项目类别:
Arginine regulation of alpha cell proliferation and function
精氨酸调节α细胞增殖和功能
- 批准号:
10609909 - 财政年份:2022
- 资助金额:
$ 38.13万 - 项目类别:
Regulation of alpha-cell glucagon secretion by mitochondrial anaplerosis-cataplerosis
线粒体回补-回补对α细胞胰高血糖素分泌的调节
- 批准号:
10607392 - 财政年份:2022
- 资助金额:
$ 38.13万 - 项目类别:
Targeting alpha-cell GPCRs to stimulate glucagon and counter hypoglycemia
靶向 α 细胞 GPCR 刺激胰高血糖素并对抗低血糖
- 批准号:
10675646 - 财政年份:2022
- 资助金额:
$ 38.13万 - 项目类别:
Elucidating alpha cell defects in human type 1 diabetes using precision cut pancreas slice-on-a-chip coupled with high spatio-temporal microscopy
使用精密切割的胰腺切片结合高时空显微镜阐明人类 1 型糖尿病的 α 细胞缺陷
- 批准号:
457552 - 财政年份:2021
- 资助金额:
$ 38.13万 - 项目类别:
Studentship Programs
Defining alpha-cell proglucagon processing for type 2 diabetes treatment
定义 2 型糖尿病治疗的 α 细胞胰高血糖素原加工过程
- 批准号:
10331361 - 财政年份:2020
- 资助金额:
$ 38.13万 - 项目类别:
In vivo systems to discover mechanisms regulating human islet alpha cell function
体内系统发现调节人类胰岛α细胞功能的机制
- 批准号:
10623306 - 财政年份:2020
- 资助金额:
$ 38.13万 - 项目类别:
Defining alpha-cell PC1/3 expression regulation for type 2 diabetes
定义 2 型糖尿病的 α 细胞 PC1/3 表达调控
- 批准号:
10376866 - 财政年份:2020
- 资助金额:
$ 38.13万 - 项目类别:














{{item.name}}会员




